156 related articles for article (PubMed ID: 9926361)
21. Oxidation and antioxidation of human low-density lipoprotein and plasma exposed to 3-morpholinosydnonimine and reagent peroxynitrite.
Thomas SR; Davies MJ; Stocker R
Chem Res Toxicol; 1998 May; 11(5):484-94. PubMed ID: 9585479
[TBL] [Abstract][Full Text] [Related]
22. Dichlorodihydrofluorescein and dihydrorhodamine 123 are sensitive indicators of peroxynitrite in vitro: implications for intracellular measurement of reactive nitrogen and oxygen species.
Crow JP
Nitric Oxide; 1997 Apr; 1(2):145-57. PubMed ID: 9701053
[TBL] [Abstract][Full Text] [Related]
23. Reaction of peroxynitrite with reduced nicotinamide nucleotides, the formation of hydrogen peroxide.
Kirsch M; de Groot H
J Biol Chem; 1999 Aug; 274(35):24664-70. PubMed ID: 10455133
[TBL] [Abstract][Full Text] [Related]
24. Flow injection chemiluminescence analysis of phenolic compounds using the NCS-luminol system.
Haghighi B; Dadashvand R
Anal Bioanal Chem; 2006 Mar; 384(5):1246-53. PubMed ID: 16485089
[TBL] [Abstract][Full Text] [Related]
25. Detection of superoxide and peroxynitrite in model systems and mitochondria by the luminol analogue L-012.
Daiber A; Oelze M; August M; Wendt M; Sydow K; Wieboldt H; Kleschyov AL; Munzel T
Free Radic Res; 2004 Mar; 38(3):259-69. PubMed ID: 15129734
[TBL] [Abstract][Full Text] [Related]
26. Phenol derivatives as enhancers and inhibitors of luminol-H2O2-horseradish peroxidase chemiluminescence.
Navas Díaz A; García Sánchez F; González Garcia JA
J Biolumin Chemilumin; 1998; 13(2):75-84. PubMed ID: 9633010
[TBL] [Abstract][Full Text] [Related]
27. Kinetics of superoxide dismutase- and iron-catalyzed nitration of phenolics by peroxynitrite.
Beckman JS; Ischiropoulos H; Zhu L; van der Woerd M; Smith C; Chen J; Harrison J; Martin JC; Tsai M
Arch Biochem Biophys; 1992 Nov; 298(2):438-45. PubMed ID: 1416975
[TBL] [Abstract][Full Text] [Related]
28. Stimulatory and inhibitory action of nitric oxide donor agents vs. nitrovasodilators on reactive oxygen production by isolated polymorphonuclear leukocytes.
Pieper GM; Clarke GA; Gross GJ
J Pharmacol Exp Ther; 1994 May; 269(2):451-6. PubMed ID: 8182511
[TBL] [Abstract][Full Text] [Related]
29. On the use of the quenching of luminol luminescence to evaluate SOD activity.
Lissi E; Pascual C; del Castillo MD
Free Radic Biol Med; 1994 Jun; 16(6):833-7. PubMed ID: 8070688
[TBL] [Abstract][Full Text] [Related]
30. Quantification of total oxidant scavenging capacity of antioxidants for peroxynitrite, peroxyl radicals, and hydroxyl radicals.
Regoli F; Winston GW
Toxicol Appl Pharmacol; 1999 Apr; 156(2):96-105. PubMed ID: 10198274
[TBL] [Abstract][Full Text] [Related]
31. In vitro study of the antioxidant properties of non steroidal anti-inflammatory drugs by chemiluminescence and electron spin resonance (ESR).
Mouithys-Mickalad AM; Zheng SX; Deby-Dupont GP; Deby CM; Lamy MM; Reginster JY; Henrotin YE
Free Radic Res; 2000 Nov; 33(5):607-21. PubMed ID: 11200092
[TBL] [Abstract][Full Text] [Related]
32. The comparative toxicity of nitric oxide and peroxynitrite to Escherichia coli.
Brunelli L; Crow JP; Beckman JS
Arch Biochem Biophys; 1995 Jan; 316(1):327-34. PubMed ID: 7840633
[TBL] [Abstract][Full Text] [Related]
33. The peroxynitrite generator, SIN-1, becomes a nitric oxide donor in the presence of electron acceptors.
Singh RJ; Hogg N; Joseph J; Konorev E; Kalyanaraman B
Arch Biochem Biophys; 1999 Jan; 361(2):331-9. PubMed ID: 9882464
[TBL] [Abstract][Full Text] [Related]
34. Formation of phospholipid hydroperoxides and its inhibition by alpha-tocopherol in rat brain synaptosomes induced by peroxynitrite.
Shi H; Noguchi N; Xu Y; Niki E
Biochem Biophys Res Commun; 1999 Apr; 257(3):651-6. PubMed ID: 10208838
[TBL] [Abstract][Full Text] [Related]
35. Protective effects of dihydropyridine Ca-blockers against endothelial cell oxidative injury due to combined nitric oxide and superoxide.
Mak IT; Zhang J; Weglicki WB
Pharmacol Res; 2002 Jan; 45(1):27-33. PubMed ID: 11820858
[TBL] [Abstract][Full Text] [Related]
36. The role of superoxide anion in the inhibitory effect of SIN-1 in thrombin-activated human platelet adhesion.
Cardoso MH; Morganti RP; Lilla S; Murad F; De Nucci G; Antunes E; Marcondes S
Eur J Pharmacol; 2010 Feb; 627(1-3):229-34. PubMed ID: 19895807
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of MIP-1alpha-induced human neutrophil and monocyte chemotactic activity by reactive oxygen and nitrogen metabolites.
Sato E; Simpson KL; Grisham MB; Koyama S; Robbins RA
J Lab Clin Med; 2000 Feb; 135(2):161-9. PubMed ID: 10695661
[TBL] [Abstract][Full Text] [Related]
38. Homolytic pathways drive peroxynitrite-dependent Trolox C oxidation.
Botti H; Trujillo M; Batthyány C; Rubbo H; Ferrer-Sueta G; Radi R
Chem Res Toxicol; 2004 Oct; 17(10):1377-84. PubMed ID: 15487899
[TBL] [Abstract][Full Text] [Related]
39. Peroxynitrite inactivates tissue plasminogen activator.
Nielsen VG; Crow JP; Zhou F; Parks DA
Anesth Analg; 2004 May; 98(5):1312-7, table of contents. PubMed ID: 15105207
[TBL] [Abstract][Full Text] [Related]
40. The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide.
Pryor WA; Squadrito GL
Am J Physiol; 1995 May; 268(5 Pt 1):L699-722. PubMed ID: 7762673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
